Funder: NRC Research Associateship Programs
Due Dates: May 1, 2025
Funding Amounts: Base stipend approximately $73,000/year plus $3,000 travel allowance and $3,000 annual supplement; experience-based stipend increases possible.
Summary: Supports postdoctoral and senior researchers in developing vaccines and immunotherapeutics against highly pathogenic hantaviruses, arenaviruses, and orthopoxviruses through preclinical research including animal model development.
Key Information: Open to U.S. citizens, permanent residents, and non-U.S. citizens; research conducted at USAMRIID in BSL-2 to BSL-4 labs; relocation and health insurance benefits included.